![Breaking Science in Gastrointestinal Cancers with Michel P. Ducreux – ESMO](https://oncodaily.com/pub/uploads/2024/07/esmo-f-1.png)
Photo taken from ESMO/LinkedIn
Jul 22, 2024, 11:36
Breaking Science in Gastrointestinal Cancers with Michel P. Ducreux – ESMO
ESMO shared on LinkedIn:
“For ESMO members: Breaking Science in Gastrointestinal Cancers.
Michel P. Ducreux presents his findings on Sequences of regorafenib and trifluridine/tipiracil after failure of standard therapies for mCRC.
Explore this video and the entire series on OncologyPRO now.”
Source: ESMO/LinkedIn